주식/증권
📈 긍정적
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
요약
Novavax has had an impressive run over the past six months as its shares have beaten the S&P 500 by 27.6%. The stock now trades at $9.21, marking a 37.6% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.